News
European Investment Bank and CureVac sign €75 million loan agreement for development of vaccine candidate against SARS-CoV-2
CureVac’s mRNA technology platform has believed to have shown potential in the clinical development and production of mRNA based vaccines and therapeutics.
The European Molecular Biology Organisation extends lifetime membership to NCBS scientist Sumantra Chattarji
It is believed that EMBO bestows lifetime membership to only a few selected scientists across the world who have done outstanding work in their respective fields.
